Sign Up
Stories
Atara Biotherapeutics at Health Care Conference
Share
Advancements in Cancer Treatment and Mar...
Allogene Therapeutics Restates Financial...
Autolus Thrives with $350M Offering and ...
AB-2100 Phase 1/2 Trial Initiated
AI-Powered Antigen Research Partnership
Affini-T Therapeutics at J.P. Morgan Hea...
Overview
API
Atara Biotherapeutics, a prominent player in T-cell immunotherapy, will be represented by its CEO at a cell therapy panel during the Cowen 44th Annual Health Care Conference. The company specializes in off-the-shelf cell therapies for cancer and autoimmune disorders utilizing its innovative EBV T-cell platform.
Ask a question
How does Atara Biotherapeutics' EBV T-cell platform differentiate its therapies from others in the market?
How might Atara's advancements in immunotherapy influence future treatments for cancer and autoimmune diseases?
What potential impact could Atara's participation in the conference have on the field of cell therapy and healthcare industry as a whole?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage